KCMC PHARMACOVIGILANCE UNIT
Kilimanjaro Christian Medical Centre (KCMC) which was established in 1971 is an institution of the Good Samaritan Foundation the owner and founder of the centre. It is located in Moshi, Kilimanjaro region, Northern Tanzania.
The KCMC Drug information office was strengthened in 2006 to be run by the clinical departments. Located in the main Pharmacy it aims to promote a pharmacovigilance culture and document Adverse Drug Reactions in KCMC.
KCMC is one of the four referral hospitals in Tanzania. It is a teaching What is Pharmacovigilance?
Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems. (WHO, 2006).
The history of pharmacovigilance goes back to 1965 during the 18th World Health Assembly, which drew attention to the problem of adverse drug reaction monitoring. After three more meetings the International Drug Monitoring Programme came into being in 1970. After 35 years the programme includes 78 countries including Tanzania.
Why pharmacovigilance and why now?
Annual Activity Report
History of Pharmacovigilance in Tanzania
Pharmacovigilance history in Tanzania can be traced back to 1989 in then Muhimbili Medical Centre (MMC). A drug information center, known as the Tanzania Drug and Toxicology Information Services (TADATIS) was established with the key functions of promoting, reporting, and analyzing ADRs, with reports submitted to the World Health Organization. Other functions included providing pharmaceutical information and education for the public and health care workers about rational use and prescribing through radio, TV, bulletins, and newspapers.
TADATIS became TFDA under the Ministry of Health (MoH) in 1998 where a risk analysis section (Pharmacovigilance) was established. Since then TFDA has established four Zonal Drug information centers. These are namely Dar es Salaam (Muhimbili), Bugando, Mbeya and Kilimanjaro (KCMC).
Number of spontaneous ADR reports received per year 1991 – 2005
Source: Tanzania Food and Drug Authority, 2006.
As noted, underreporting remains a challenge due to the following factors
TFDA plans to carry out the following activities to improve Pharmacovigilance
Source of materials: Tanzania Food and Drug Authority, WHO and Consultative Meeting Report for Pharmacovigilance prepared by Management Sciences for Health (Dat Tran, 2006)
Proposed activities include
Dr Siya Temu ( firstname.lastname@example.org)
Department of Paediatrics
Kilimanjaro Christian Medical CentreP. O. Box 3010 Moshi, Kilimanjaro+255756203107
Dr Kajiru Kilonzo ( email@example.com)
Department of Internal MedicineKilimanjaro Christian Medical Centre P. O. Box 3010 Moshi, Kilimanjaro+255756337067
Department of Internal MedicineKilimanjaro Christian Medical CentreP. O. Box 3010Moshi, Kilimanjaro
Further important links
Last modified: April , 2010. (Hans)